Concentration of homovanillic acid in the ventricular fluid of patients with Parkinson's disease and other dyskinesias.

Suppr

超能文献

作者信息

Papeschi R, Molina-Negro P, Sourkes T L, Hardy J, Bertrand C

出版信息

Neurology. 1970 Oct;20(10):991-5. doi: 10.1212/wnl.20.10.991.

DOI:10.1212/wnl.20.10.991

PMID:4919352

Abstract

摘要

相似文献

Concentration of homovanillic acid in the ventricular fluid of patients with Parkinson's disease and other dyskinesias.

Neurology. 1970 Oct;20(10):991-5. doi: 10.1212/wnl.20.10.991.

The ventricular fluid pressure and the concentration of homovanillic acid in different parts of the cerebrospinal fluid system in patients with Parkinson's disease.帕金森病患者脑脊液系统不同部位的脑室液压力和高香草酸浓度。

Confin Neurol. 1972;34(2):136-42.

Acid monoamine metabolites in the cerebrospinal fluid of patients with Parkinson's disease.

Neurology. 1972 Jan;22(1):62-7. doi: 10.1212/wnl.22.1.62.

A study of spinal fluid homovanillic acid (HVA) in patients with diseases of the nervous system.一项针对神经系统疾病患者脑脊液中高香草酸（HVA）的研究。

Mt Sinai J Med. 1972 Sep-Oct;39(5):478-85.

Confin Neurol. 1972;34(1):136-42.

[Results of stereotaxic treatment of Parkinson's syndrome and involuntary movements].

Neurol Neurochir Pol. 1967 Jan-Feb;17(1):61-6.

Ventricular fluid homovanillic acid and 5-hydroxyindoleacetic acid concentrations in patients with movement disorders.

Neurology. 1978 Dec;28(12):1249-53. doi: 10.1212/wnl.28.12.1249.

Cerebrospinal fluid monoamine catabolites in drug-induced extrapyramidal disorders.

Neuropharmacology. 1970 May;9(3):265-8. doi: 10.1016/0028-3908(70)90075-4.

The concentration of homovanillic and 5-hydroxyindoleacetic acids in ventricular and lumbar CSF. Studies in patients with extrapyramidal disorders, epilepsy, and other diseases.脑脊液心室和腰椎穿刺液中高香草酸和5-羟吲哚乙酸的浓度。锥体外系疾病、癫痫及其他疾病患者的研究。

Neurology. 1972 Nov;22(11):1151-9. doi: 10.1212/wnl.22.11.1151.

Stereotaxic brain operations in Parkinson's syndrome and related motor disturbances. Comparison of lesions in the pallidum and thalamus with those in the internal capsule.

Confin Neurol. 1967;29:Suppl:1-70.

引用本文的文献

Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease.帕金森病患者的脑脊液生化研究：寻找这种疾病潜在生物标志物的方法。

Front Cell Neurosci. 2014 Nov 11;8:369. doi: 10.3389/fncel.2014.00369. eCollection 2014.

Central catecholamine metabolism in vivo and the cognitive and motor deficits in Parkinson's disease.帕金森病中体内中枢儿茶酚胺代谢以及认知和运动缺陷

J Neurol Neurosurg Psychiatry. 1983 Oct;46(10):905-10. doi: 10.1136/jnnp.46.10.905.

[Modern treatment of parkinsonism].[帕金森病的现代治疗]

Z Neurol. 1972;202(4):257-80.

Treatment of Sydenham's chorea with a combination of L-dopa and a peripheral dopa decarboxylase inhibitor.

Psychopharmacologia. 1975 Nov 21;44(3):311-2. doi: 10.1007/BF00428914.

Correlation of clinical symptoms, HVA and 5-HIAA in csf and plasma L-DOPA in Parkinsonian patients treated with L-DOPA and L-DOPA + RO 4-4602.左旋多巴及左旋多巴+RO 4-4602治疗的帕金森病患者临床症状、脑脊液中高香草酸（HVA）和5-羟吲哚乙酸（5-HIAA）与血浆左旋多巴的相关性

Eur J Clin Pharmacol. 1977 Apr 20;11(4):255-61. doi: 10.1007/BF00607673.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验